Is MetALD an independent risk factor of all-cause mortality? A meta-analysis of 164,694 individuals from the real world

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-10-21 DOI:10.1016/j.jhep.2024.10.022

Zheng Li, Yali Shen, Zhiping Li, Dan Cao, Yue Hu

{"title":"Is MetALD an independent risk factor of all-cause mortality? A meta-analysis of 164,694 individuals from the real world","authors":"Zheng Li, Yali Shen, Zhiping Li, Dan Cao, Yue Hu","doi":"10.1016/j.jhep.2024.10.022","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors' contributions</h2>Zheng Li, Yue Hu, and Dan Cao contributed to the study conception and design. Zheng Li, Yali Shen, Zhiping Li, Dan Cao, and Yue Hu performed data acquisition, analysis, and interpretation. Zheng Li, Yali Shen, and Zhiping Li wrote the initial draft, Yue Hu and Dan Cao revised the manuscript. All authors reviewed and approved the final manuscript.</section></section><section><section><h2>Data availability statement</h2>The data that support the findings of this study are all included in this article and the supplementary material.</section></section><section><section><h2>Funding</h2>This work was jointly supported by the National Natural Science Foundation of China (Grant No. 82272746), and the Medical Science and Technology Project of Sichuan Provincial Health Commission (Grant No. 21PJ135).</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors declare no conflicts of interest.</section></section><section><section><h2>Acknowledgements</h2>The authors would like to thank Yaqin Zhao, Ningjing Lei (Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China), Xi Chen, Qing Liu, and Shihong Nie (Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China) for their valuable help in data collection and data analysis.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"66 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.10.022","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors' contributions

Zheng Li, Yue Hu, and Dan Cao contributed to the study conception and design. Zheng Li, Yali Shen, Zhiping Li, Dan Cao, and Yue Hu performed data acquisition, analysis, and interpretation. Zheng Li, Yali Shen, and Zhiping Li wrote the initial draft, Yue Hu and Dan Cao revised the manuscript. All authors reviewed and approved the final manuscript.

Data availability statement

The data that support the findings of this study are all included in this article and the supplementary material.

Funding

This work was jointly supported by the National Natural Science Foundation of China (Grant No. 82272746), and the Medical Science and Technology Project of Sichuan Provincial Health Commission (Grant No. 21PJ135).

Declaration of Competing Interest

The authors declare no conflicts of interest.

Acknowledgements

The authors would like to thank Yaqin Zhao, Ningjing Lei (Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China), Xi Chen, Qing Liu, and Shihong Nie (Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China) for their valuable help in data collection and data analysis.

查看原文本刊更多论文

MetALD 是全因死亡率的独立风险因素吗？对现实世界中 164,694 人进行的荟萃分析

章节片段作者贡献Zheng Li、Yue Hu和Dan Cao参与了研究的构思和设计。李铮、沈雅丽、李治平、曹丹和胡玥进行了数据采集、分析和解释。李铮、沈雅丽和李志平撰写了初稿，胡玥和曹丹对稿件进行了修改。本研究得到了国家自然科学基金（批准号：82272746）和四川省卫计委医学科技项目（批准号：21PJ135）的共同资助。致谢作者感谢赵雅琴、雷宁静（四川大学华西医院肿瘤中心腹部肿瘤多模式治疗科）、陈曦、刘青和聂世红（四川大学华西医院肿瘤中心放射肿瘤科）在数据收集和数据分析方面提供的宝贵帮助。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.